- Merck & Co. could maintain patents for its best-selling drug Keytruda by patenting an injectable form of the medicine, which it’s currently testing in clinical trials. Certain patents for Keytruda are up in 2028, when copies of the drug could hit the market. (Article here)
December 2, 2022
Life Sciences